tiprankstipranks
Advertisement
Advertisement

HAE Stock Latest News

Haemonetics price target raised to $105 from $90 at Raymond James
The FlyHaemonetics price target raised to $105 from $90 at Raymond James
4h ago
HAE
Haemonetics price target raised to $96 from $88 at Baird
PremiumThe Fly
Haemonetics price target raised to $96 from $88 at Baird
6h ago
HAE
Haemonetics price target raised to $95 from $89 at Barrington
PremiumThe Fly
Haemonetics price target raised to $95 from $89 at Barrington
6h ago
HAE
Haemonetics price target raised to $92 from $79 at Citi
PremiumThe Fly
Haemonetics price target raised to $92 from $79 at Citi
7h ago
HAE
Haemonetics reports Q1 adjusted EPS $1.14, consensus $1.08
PremiumThe Fly
Haemonetics reports Q1 adjusted EPS $1.14, consensus $1.08
1d ago
HAE
Haemonetics raises FY27 adjusted EPS view to up 5%-8% from up 4%-7%
PremiumThe FlyHaemonetics raises FY27 adjusted EPS view to up 5%-8% from up 4%-7%
1d ago
HAE
Haemonetics (HAE) Q1 Earnings Cheat Sheet
Premium
Pre-Earnings
Haemonetics (HAE) Q1 Earnings Cheat Sheet
3d ago
HAE
Haemonetics’ Vascade MVP system shows efficacy in electrophysiology study
Premium
The Fly
Haemonetics’ Vascade MVP system shows efficacy in electrophysiology study
4d ago
HAE
Haemonetics price target raised to $93 from $80 at BofA
PremiumThe Fly
Haemonetics price target raised to $93 from $80 at BofA
9d ago
CG
HAE
Haemonetics Adds Veteran Director as Shareholders Back Governance
PremiumCompany Announcements
Haemonetics Adds Veteran Director as Shareholders Back Governance
10d ago
8K
HAE
Haemonetics price target raised to $90 from $85 at Mizuho
PremiumThe Fly
Haemonetics price target raised to $90 from $85 at Mizuho
23d ago
HAE
Citi adds ‘downside 90-day catalyst watch’ on Haemonetics
PremiumThe Fly
Citi adds ‘downside 90-day catalyst watch’ on Haemonetics
1M ago
HAE
Haemonetics management to meet virtually with BTIG
PremiumThe FlyHaemonetics management to meet virtually with BTIG
2M ago
HAE
Haemonetics price target raised to $85 from $70 at Mizuho
Premium
The Fly
Haemonetics price target raised to $85 from $70 at Mizuho
2M ago
HAE
Haemonetics: Buy Rating Reiterated as New Apheresis Reporting Boosts Transparency; $80 Price Target Maintained
Premium
Ratings
Haemonetics: Buy Rating Reiterated as New Apheresis Reporting Boosts Transparency; $80 Price Target Maintained
2M ago
HAE
Haemonetics Unveils New Two-Segment Financial Reporting Structure
PremiumCompany Announcements
Haemonetics Unveils New Two-Segment Financial Reporting Structure
2M ago
8K
HAE
Haemonetics price target raised to $70 from $64 at Citi
PremiumThe Fly
Haemonetics price target raised to $70 from $64 at Citi
2M ago
HAE
Haemonetics upgraded to Buy at BofA on upside to guidance
PremiumThe Fly
Haemonetics upgraded to Buy at BofA on upside to guidance
3M ago
HAE
Haemonetics upgraded to Buy from Neutral at BofA
PremiumThe Fly
Haemonetics upgraded to Buy from Neutral at BofA
3M ago
HAE
Haemonetics’ Global ERP Rollout Poses Execution Risks, Potential Margin Pressure and Operational Disruption
PremiumCompany AnnouncementsHaemonetics’ Global ERP Rollout Poses Execution Risks, Potential Margin Pressure and Operational Disruption
3M ago
HAE
Haemonetics price target lowered to $89 from $94 at Barrington
Premium
The Fly
Haemonetics price target lowered to $89 from $94 at Barrington
3M ago
HAE
Haemonetics Earnings Call Highlights Growth Amid Headwinds
Premium
Company Announcements
Haemonetics Earnings Call Highlights Growth Amid Headwinds
3M ago
HAE

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >